Trade and Intellectual Property

Whenever I hear about compulsory licensing done pursuant to the TRIPS Agreement and related instruments, I wonder whether IP companies will lobby for a formal complaint against the practice.  It is permitted in principle, of course, but there is always the possibility that the applicable rules have not been followed.

Although ignored by most media outlets (but not IP Watch), the India Patent Controller is considering an application from Indian generic pharmaceutical company Natco to produce two drugs for export to Nepal under compulsory licence. If approved and implemented, this would be the second compulsory licence issued for export under